Selected Current Investments
Airna
Airna is a privately held Biotech company in Tuebingen, Germany. It is developing a unique and proprietary approach to RNA editing, as an alternative to DNA editing, to develop safe gene therapies for a variety of common genetic diseases.
Animol Discovery
Animol Discovery is a privately held Animal Health company in Boston, MA. Its proprietary screening platform accelerates the identification of medicines for unmet needs in animals by using a highly advanced approach to small molecule discovery and development.
BlueWhale Bio
BlueWhale Bio is a privately held Life Science Tools company in Philadelphia, PA. It is developing a technology platform and product portfolio intended to bring the benefits of cell and gene therapy manufacturing to more patients faster and at lower costs.
Enko
Enko is a privately held Agricultural Biotechnology company in Mystic, CT. Its proprietary technology platform represents a revolutionary approach to rapidly discover novel, safe, and economical crop protection products that are needed to ensure sustainable food production.
Etherna
Etherna is a privately held company located in Niel, Belgium. It it is commercial stage Biotech company that has developed an integrated set of platform technologies that are overcoming challenges facing the development of next generation mRNA therapeutics.
Flywheel
Flywheel is a privately held company in Minneapolis, MN. It is a pioneering Medical Imaging data and artificial intelligence platform powering healthcare innovation through streamlined medical imaging data management, curation and analysis.
Helaxy
Helaxy is a privately held diagnostics tools company located in Singapore. The company is bringing breakthrough Next Generation Sequencing genotyping solutions to hospitals and laboratories worldwide through an automated and user-friendly instrument based on fluidics sample preparation.
LevitasBio
LevitasBio is a privately held Life Science Tools company in Menlo Park, CA. It is commercializing a highly innovative cellular separation and analysis technology, based on magnetic levitation technology. In mixed cellular samples analyzed for research and diagnostics purposes, this technology allows for more accurate identification of the different cell types present.
Mercy Bioanalytics
Mercy Bioanalytics is a privately held company in Boston, MA. It is developing the first and only test for early-stage cancer detection based on the analysis of single extracellular vesicles in the blood.
Ori Biotech
Ori Biotech is a privately held Biotech company in London, UK, that has developed a flexible manufacturing platform that automates and standardizes Cell and Gene Therapy manufacturing. This allows therapeutic developers to bring their products to patients in a more scalable and efficient manner.
Orogen Therapeutics
Orogen Therapeutics is a privately held small molecule discovery company based in Woburn, MA. By applying its proprietary DNA encoded libraries screening technology, it is developing novel drugs for auto-immune diseases.
SkylineDx
SkylineDx is a privately held Molecular Diagnostic company based in Rotterdam, The Netherlands. It is commercial-stage, focused on the genomic profiling of a cancerous tumor and as such determine the type and status of the disease to predict an individual patient’s response to treatment.
Telesis Bio
Telesis Bio is a private Life Science Tools company located in San Diego, CA. It has commercialized a leading molecular biology automation solutions platform for DNA and RNA synthesis. This platform allows scientists to accelerate their development of novel biopharma therapeutics.
Vigilant Biosciences
Vigilant Biosciences is a privately held Molecular Diagnostics company located in Austin, TX. It is a leading innovator and developer of solutions that aid in the early detection and intervention of oral and oropharyngeal cancer.
Selected Exits
Celsee
Celsee is a Life Science Tools company in Ann Arbor, MI. It develops and sells unique gravity based single-cell analysis systems that allow for the analysis of molecular signatures of millions of individual cells. Acquired by Bio-Rad April 2020.
Cerevel Therapeutics
Cerevel Therapeutics (NASDAQ:CERE) is a public Biopharmaceutical company in Cambridge, MA. It is developing pre-commercial neuroscience compounds to treat a variety of Central Nervous System disorders including Parkinson’s, epilepsy and schizophrenia. Acquired by Abbvie August 2024.
Decipher Biosciences
Decipher Biosciences is a Molecular Diagnostics company in San Diego, CA. It is a leader in the field of urological cancer genomics, which measures the biological activity of a patient’s entire tumor genome, and as such helps physicians to improve therapy selection. Acquired by Veracyte March 2021.
Ginkgo Bioworks
Ginkgo Bioworks (NYSE:DNA) is a public company in Boston, MA. It is a commercial stage Biotech company that specializes in using genetic engineering to design custom microbes for a wide variety of life sciences and industrial applications. Public since September 2021.
Quanterix
Quanterix (NASDAQ:QTRX) is a public Life Science Tools company located in Billerica, MA. It develops and sells uniquely precise and sensitive instrumentation to analyze and detect biomolecules for a variety of life sciences research and diagnostic applications. Public since December 2017.